Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
OBJECTIVES: To determine the clinical and cost-effectiveness of different classes of antipsychotic drug treatment in people with schizophrenia responding inadequately to, or having unacceptable side-effects from, their current medication. DESIGN: Two pragmatic, randomised controlled trials (RCTs) we...
Main Authors: | Lewis, S, Davies, L, Jones, P, Barnes, T, Murray, R, Kerwin, R, Taylor, D, Hayhurst, K, Markwick, A, Lloyd, H, Dunn, G |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2006
|
Similar Items
-
Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment
by: Lewis, S, et al.
Published: (2006) -
Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment
by: S Lewis, et al.
Published: (2006-05-01) -
The effects of antipsychotic drugs on depression level in patients with schizophrenia: clozapine vs. other atypical antipsychotics
by: Hülya Ertekin, et al.
Published: (2016-08-01) -
Attitudes to atypical and conventional antipsychotic drug treatment in clinicians participating in the cutlass study.
by: Lloyd, H, et al.
Published: (2005) -
Inhibition of Epstein-Barr Virus Lytic Reactivation by the Atypical Antipsychotic Drug Clozapine
by: Abbie G. Anderson, et al.
Published: (2019-05-01)